The activation of CB1R in the liver is associated with obesity and metabolic complications such as insulin resistance and dyslipidemia by promoting the fatty acid uptake, lipogenesis, and adipogenesis [8]. This evidence concerns the gene CNR1 and metabolic syndrome.